Literature DB >> 3235801

Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts.

H Van Bossuyt1, R B De Zanger, E Wisse.   

Abstract

The cellular and subcellular distribution of biologically tritiated Salmonella abortus equi lipopolysaccharide (LPS) was studied at different time intervals after intravenous injection in rats. At 1 min after injection of LPS via the portal vein label was present over Kupffer cell phagosomes. Between 30 min and 7 days after injection, silver grains were mainly associated with phagosomes and lysosomes and occasionally with the membrane of Kupffer cells. A few parenchymal cells were labeled at 5 min in their mitochondria, cell membrane and the periphery of the cell. Radioactivity was also present in the rough endoplasmic reticulum (from 15 min), fat droplets and the nucleus (from 3 h) up to 7 days. Sinusoidal endothelial and fat-storing cells were never labeled. In conclusion, both Kupffer cells and parenchymal cells play a role in the uptake of LPS by the liver. The uptake and processing of endotoxin is rapid, since label is found early after administration and radioactivity is detected in the bile within 1 h. This radioactivity represents non-detoxified LPS, since it is lethal for galactosamine-sensitised mice after extraction with hot phenol/water. However, in the presence of bile salts, the LPS is non-lethal and not capable of clotting the limulus amebocyte lysate. LPS injection causes bile flow reduction within 45 min.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235801     DOI: 10.1016/s0168-8278(88)80005-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice.

Authors:  Y Hori; H Ohyanagi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Release of TNF-alpha from lipopolysaccharide (LPS)-stimulated Kupffer cells in serum- and nutrient-free medium.

Authors:  A Zipfel; M Schenk; B Metzdorf; C Bode; R Viebahn
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

3.  Biliary excretion of lipopolysaccharide is microtubule-dependent in isolated perfused rat liver.

Authors:  Y Hori; H Ohyanagi
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

4.  Tumour necrosis factor alpha secretion in leporine endotoxaemia: role of the liver and effects of hepatic ischaemia.

Authors:  I L Badger; P Townsend; J A Buckels
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

5.  Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M.

Authors:  A Glatman-Freedman; A J Mednick; N Lendvai; A Casadevall
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

6.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

Review 7.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Chylomicrons enhance endotoxin excretion in bile.

Authors:  T E Read; H W Harris; C Grunfeld; K R Feingold; M C Calhoun; J P Kane; J H Rapp
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Continuous infusion of Escherichia coli endotoxin in vivo primes in vitro superoxide anion release in rat polymorphonuclear leukocytes and Kupffer cells in a time-dependent manner.

Authors:  A M Mayer; J A Spitzer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Starring role of toll-like receptor-4 activation in the gut-liver axis.

Authors:  Simone Carotti; Michele Pier Luca Guarino; Umberto Vespasiani-Gentilucci; Sergio Morini
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.